0.09Open0.09Pre Close0 Volume1 Open Interest5.00Strike Price0.00Turnover404.64%IV113.87%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.09Extrinsic Value100Contract SizeAmericanOptions Type0.1585Delta0.1765Gamma26.44Leverage Ratio-0.0219Theta0.0001Rho4.19Eff Leverage0.0008Vega
Oramed Pharmaceuticals Stock Discussion
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
NEW YORK, Oct. 7, 2024 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced the execution of definitive agreements for the restructuring of a portion of its existing Senior Secured Promissory Note from Scilex Holding Compa...
your turn tonight?
$Calyxt (CLXT.US)$ $Viveve Medical (VIVE.US)$ $Celyad Oncology (CYAD.US)$ $Bit Digital (BTBT.US)$ $Rivian Automotive (RIVN.US)$ $Oramed Pharmaceuticals (ORMP.US)$ $MGO Global (MGOL.US)$ $Tritium DCFC (DCFC.US)$ $Bed Bath & Beyond Inc (BBBY.US)$ $BIT Mining (BTCM.US)$
No comment yet